Medicalgorithmics ends the year with record 74% revenue growth and positive EBITDA in Q4 2025.
Medicalgorithmics S.A., a developer of globally innovative AI algorithms and ECG analysis platforms, is closing a groundbreaking fourth quarter of 2025 with estimated consolidated sales revenue of PLN 10.2 million, representing an increase of +74% year-on-year and +42% quarter-on-quarter. At the same time, the Company recorded a positive estimated EBITDA of PLN 1.0 million. The above-average results recorded by the Company are the result of consistent scale building resulting from the effective transformation of the business model, which is based on the sale of ECG analysis software, as well as the development of R&D projects, led by the groundbreaking VCAST technology.
Estimated revenues for the fourth quarter of 2025.